CO4A3_HUMAN - dbPTM
CO4A3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CO4A3_HUMAN
UniProt AC Q01955
Protein Name Collagen alpha-3(IV) chain
Gene Name COL4A3
Organism Homo sapiens (Human).
Sequence Length 1670
Subcellular Localization Secreted, extracellular space, extracellular matrix, basement membrane. Colocalizes with COL4A4 and COL4A5 in GBM, tubular basement membrane (TBM) and synaptic basal lamina (BL)..
Protein Description Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen.; Tumstatin, a cleavage fragment corresponding to the collagen alpha 3(IV) NC1 domain, possesses both anti-angiogenic and anti-tumor cell activity; these two anti-tumor properties may be regulated via RGD-independent ITGB3-mediated mechanisms..
Protein Sequence MSARTAPRPQVLLLPLLLVLLAAAPAASKGCVCKDKGQCFCDGAKGEKGEKGFPGPPGSPGQKGFTGPEGLPGPQGPKGFPGLPGLTGSKGVRGISGLPGFSGSPGLPGTPGNTGPYGLVGVPGCSGSKGEQGFPGLPGTLGYPGIPGAAGLKGQKGAPAKEEDIELDAKGDPGLPGAPGPQGLPGPPGFPGPVGPPGPPGFFGFPGAMGPRGPKGHMGERVIGHKGERGVKGLTGPPGPPGTVIVTLTGPDNRTDLKGEKGDKGAMGEPGPPGPSGLPGESYGSEKGAPGDPGLQGKPGKDGVPGFPGSEGVKGNRGFPGLMGEDGIKGQKGDIGPPGFRGPTEYYDTYQEKGDEGTPGPPGPRGARGPQGPSGPPGVPGSPGSSRPGLRGAPGWPGLKGSKGERGRPGKDAMGTPGSPGCAGSPGLPGSPGPPGPPGDIVFRKGPPGDHGLPGYLGSPGIPGVDGPKGEPGLLCTQCPYIPGPPGLPGLPGLHGVKGIPGRQGAAGLKGSPGSPGNTGLPGFPGFPGAQGDPGLKGEKGETLQPEGQVGVPGDPGLRGQPGRKGLDGIPGTPGVKGLPGPKGELALSGEKGDQGPPGDPGSPGSPGPAGPAGPPGYGPQGEPGLQGTQGVPGAPGPPGEAGPRGELSVSTPVPGPPGPPGPPGHPGPQGPPGIPGSLGKCGDPGLPGPDGEPGIPGIGFPGPPGPKGDQGFPGTKGSLGCPGKMGEPGLPGKPGLPGAKGEPAVAMPGGPGTPGFPGERGNSGEHGEIGLPGLPGLPGTPGNEGLDGPRGDPGQPGPPGEQGPPGRCIEGPRGAQGLPGLNGLKGQQGRRGKTGPKGDPGIPGLDRSGFPGETGSPGIPGHQGEMGPLGQRGYPGNPGILGPPGEDGVIGMMGFPGAIGPPGPPGNPGTPGQRGSPGIPGVKGQRGTPGAKGEQGDKGNPGPSEISHVIGDKGEPGLKGFAGNPGEKGNRGVPGMPGLKGLKGLPGPAGPPGPRGDLGSTGNPGEPGLRGIPGSMGNMGMPGSKGKRGTLGFPGRAGRPGLPGIHGLQGDKGEPGYSEGTRPGPPGPTGDPGLPGDMGKKGEMGQPGPPGHLGPAGPEGAPGSPGSPGLPGKPGPHGDLGFKGIKGLLGPPGIRGPPGLPGFPGSPGPMGIRGDQGRDGIPGPAGEKGETGLLRAPPGPRGNPGAQGAKGDRGAPGFPGLPGRKGAMGDAGPRGPTGIEGFPGPPGLPGAIIPGQTGNRGPPGSRGSPGAPGPPGPPGSHVIGIKGDKGSMGHPGPKGPPGTAGDMGPPGRLGAPGTPGLPGPRGDPGFQGFPGVKGEKGNPGFLGSIGPPGPIGPKGPPGVRGDPGTLKIISLPGSPGPPGTPGEPGMQGEPGPPGPPGNLGPCGPRGKPGKDGKPGTPGPAGEKGNKGSKGEPGPAGSDGLPGLKGKRGDSGSPATWTTRGFVFTRHSQTTAIPSCPEGTVPLYSGFSFLFVQGNQRAHGQDLGTLGSCLQRFTTMPFLFCNVNDVCNFASRNDYSYWLSTPALMPMNMAPITGRALEPYISRCTVCEGPAIAIAVHSQTTDIPPCPHGWISLWKGFSFIMFTSAGSEGTGQALASPGSCLEEFRASPFLECHGRGTCNYYSNSYSFWLASLNPERMFRKPIPSTVKAGELEKIISRCQVCMKKRH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSARTAPRP
------CCCCCCCCH
37.4522210691
5Phosphorylation---MSARTAPRPQVL
---CCCCCCCCHHHH
40.5022210691
28PhosphorylationLAAAPAASKGCVCKD
HHHCHHHHCCCEECC
31.5222210691
235PhosphorylationERGVKGLTGPPGPPG
CCCCCCCCCCCCCCC
57.20-
243PhosphorylationGPPGPPGTVIVTLTG
CCCCCCCEEEEEEEC
16.91-
249PhosphorylationGTVIVTLTGPDNRTD
CEEEEEEECCCCCCC
36.98-
253N-linked_GlycosylationVTLTGPDNRTDLKGE
EEEECCCCCCCCCCC
52.46UniProtKB CARBOHYD
382PhosphorylationGPPGVPGSPGSSRPG
CCCCCCCCCCCCCCC
21.73-
386PhosphorylationVPGSPGSSRPGLRGA
CCCCCCCCCCCCCCC
48.7024719451
835PhosphorylationQQGRRGKTGPKGDPG
CCCCCCCCCCCCCCC
62.63-
1001UbiquitinationGPRGDLGSTGNPGEP
CCCCCCCCCCCCCCC
40.2017370265
1059PhosphorylationDKGEPGYSEGTRPGP
CCCCCCCCCCCCCCC
35.1524719451
1206MethylationFPGLPGRKGAMGDAG
CCCCCCCCCCCCCCC
57.86-
1206"N6,N6-dimethyllysine"FPGLPGRKGAMGDAG
CCCCCCCCCCCCCCC
57.86-
1246PhosphorylationGNRGPPGSRGSPGAP
CCCCCCCCCCCCCCC
38.96-
1249PhosphorylationGPPGSRGSPGAPGPP
CCCCCCCCCCCCCCC
21.03-
1379UbiquitinationQGEPGPPGPPGNLGP
CCCCCCCCCCCCCCC
44.1417370265
1401PhosphorylationGKDGKPGTPGPAGEK
CCCCCCCCCCCCCCC
33.3322210691
1414UbiquitinationEKGNKGSKGEPGPAG
CCCCCCCCCCCCCCC
75.7917370265
1422PhosphorylationGEPGPAGSDGLPGLK
CCCCCCCCCCCCCCC
30.5228111955
1429AcetylationSDGLPGLKGKRGDSG
CCCCCCCCCCCCCCC
69.1923236377
1435PhosphorylationLKGKRGDSGSPATWT
CCCCCCCCCCCCCEE
43.957768924
1443PhosphorylationGSPATWTTRGFVFTR
CCCCCEEECEEEEEE
21.98-
1452PhosphorylationGFVFTRHSQTTAIPS
EEEEEECCCCCCCCC
26.407768924
1519PhosphorylationNFASRNDYSYWLSTP
CCCCCCCCCEEECCC
13.7524275569
1525PhosphorylationDYSYWLSTPALMPMN
CCCEEECCCCCCCCC
15.4824275569
1537PhosphorylationPMNMAPITGRALEPY
CCCCCCCCCCCCCCC
21.4024275569
1544PhosphorylationTGRALEPYISRCTVC
CCCCCCCCHHHCEEE
11.3624275569
1546PhosphorylationRALEPYISRCTVCEG
CCCCCCHHHCEEECC
18.5624275569
1612 (in isoform 2)Phosphorylation-36.547758473
1648PhosphorylationMFRKPIPSTVKAGEL
HHCCCCCCCCHHHHH
46.6922199227
1649PhosphorylationFRKPIPSTVKAGELE
HCCCCCCCCHHHHHH
22.2222199227

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
1435SPhosphorylationKinaseCOL4A3BPQ9Y5P4
PSP
1435SPhosphorylationKinasePRKACAP00517
GPS
1452SPhosphorylationKinasePRKACAP00517
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CO4A3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CO4A3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of CO4A3_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
Note=Autoantibodies against the NC1 domain of alpha 3(IV) are found in Goodpasture syndrome, an autoimmune disease of lung and kidney.
203780
141200Hematuria, benign familial (BFH)
104200Alport syndrome, autosomal dominant (APSAD)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CO4A3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Ubiquitylation
ReferencePubMed
"Tryptic digestion of ubiquitin standards reveals an improved strategyfor identifying ubiquitinated proteins by mass spectrometry.";
Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.;
Proteomics 7:868-874(2007).
Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-1414, AND MASSSPECTROMETRY.

TOP